O95342 · ABCBB_HUMAN

  • Protein
    Bile salt export pump
  • Gene
    ABCB11
  • Status
    UniProtKB reviewed (Swiss-Prot)
  • Amino acids
  • Protein existence
    Evidence at protein level
  • Annotation score
    5/5

Function

function

Catalyzes the transport of the major hydrophobic bile salts, such as taurine and glycine-conjugated cholic acid across the canalicular membrane of hepatocytes in an ATP-dependent manner, therefore participates in hepatic bile acid homeostasis and consequently to lipid homeostasis through regulation of biliary lipid secretion in a bile salts dependent manner (PubMed:15791618, PubMed:16332456, PubMed:18985798, PubMed:19228692, PubMed:20010382, PubMed:20398791, PubMed:22262466, PubMed:24711118, PubMed:29507376, PubMed:32203132).
Transports taurine-conjugated bile salts more rapidly than glycine-conjugated bile salts (PubMed:16332456).
Also transports non-bile acid compounds, such as pravastatin and fexofenadine in an ATP-dependent manner and may be involved in their biliary excretion (PubMed:15901796, PubMed:18245269).

Catalytic activity

  • ATP + cholate(in) + H2O = ADP + cholate(out) + H+ + phosphate
    This reaction proceeds in the forward direction.
  • ATP + H2O + taurocholate(in) = ADP + H+ + phosphate + taurocholate(out)
    This reaction proceeds in the forward direction.
  • ATP + glycocholate(in) + H2O = ADP + glycocholate(out) + H+ + phosphate
    This reaction proceeds in the forward direction.
  • ATP + glycochenodeoxycholate(in) + H2O = ADP + glycochenodeoxycholate(out) + H+ + phosphate
    This reaction proceeds in the forward direction.
  • ATP + H2O + taurochenodeoxycholate(in) = ADP + H+ + phosphate + taurochenodeoxycholate(out)
    This reaction proceeds in the forward direction.
  • ATP + glycoursodeoxycholate(in) + H2O = ADP + glycoursodeoxycholate(out) + H+ + phosphate
    This reaction proceeds in the forward direction.
  • ATP + H2O + tauroursodeoxycholate(in) = ADP + H+ + phosphate + tauroursodeoxycholate(out)
    This reaction proceeds in the forward direction.
  • ATP + H2O + taurodeoxycholate(in) = ADP + H+ + phosphate + taurodeoxycholate(out)
    This reaction proceeds in the forward direction.
  • ATP + H2O + taurolithocholate 3-sulfate(in) = ADP + H+ + phosphate + taurolithocholate 3-sulfate(out)
    This reaction proceeds in the forward direction.
  • ATP + H2O + pravastatin(in) = ADP + H+ + phosphate + pravastatin(out)
    This reaction proceeds in the forward direction.

Activity regulation

The uptake of taurocholate is inhibited by taurolithocholate sulfate with an IC50 of 9 uM (PubMed:16332456).
Pravastatin competitively inhibits the transport of taurocholic acid (PubMed:15901796, PubMed:18985798).
Cyclosporin A, glibenclamide, rifampicin and troglitazonestrongly competitively inhibit the transport activity of taurocholate (PubMed:18985798, PubMed:32203132).
The canalicular transport activity of taurocholate is strongly dependent on canalicular membrane cholesterol content (PubMed:19228692).
The uptake of taurocholate is increased by short- and medium-chain fatty acids (PubMed:20398791).
Cholesterol increases transport capacity of taurocholate without affecting the affinity for the substrate (PubMed:24711118).

Kinetics

KM SUBSTRATE pH TEMPERATURE[C] NOTES EVIDENCE
30.4 μMtaurocholate
6.2 μMtaurocholate
21.7 μMglycocholate
6.6 μMtaurochenodeoxycholate
7.5 μMglycochenodeoxycholate
9.5 μMtaurolithocholate sulfate
4.61 μMtaurocholate
4.64 μMtaurocholate
124 μMpravastatin
19.9 μMtaurocholate
Vmax pH TEMPERATURE[C] NOTES EVIDENCE
232 pmol/min/mgfor taurocholate transport
2510 pmol/min/mgfor taurocholate transport
2310 pmol/min/mgfor taurocholate transport
4290 pmol/min/mgfor taurocholate transport
1220 pmol/min/mgfor pravastatin transport
98.5 pmol/min/mgfor taurocholate transport

Features

Showing features for binding site.

TypeIDPosition(s)Description
Binding site455-462ATP 1 (UniProtKB | ChEBI)
Binding site1113-1120ATP 2 (UniProtKB | ChEBI)

GO annotations

AspectTerm
Cellular Componentapical plasma membrane
Cellular Componentcell surface
Cellular Componentendosome
Cellular Componentextracellular exosome
Cellular ComponentGolgi membrane
Cellular Componentintercellular canaliculus
Cellular Componentintracellular canaliculus
Cellular Componentmembrane
Cellular Componentplasma membrane
Cellular Componentrecycling endosome
Cellular Componentrecycling endosome membrane
Molecular FunctionABC-type bile acid transporter activity
Molecular FunctionABC-type xenobiotic transporter activity
Molecular FunctionATP binding
Molecular FunctionATP hydrolysis activity
Molecular Functionbile acid transmembrane transporter activity
Molecular Functioncanalicular bile acid transmembrane transporter activity
Molecular Functioncarbohydrate transmembrane transporter activity
Biological Processbile acid and bile salt transport
Biological Processbile acid biosynthetic process
Biological Processbile acid metabolic process
Biological Processbile acid signaling pathway
Biological Processcanalicular bile acid transport
Biological Processcholesterol homeostasis
Biological Processfatty acid metabolic process
Biological Processlipid homeostasis
Biological Processphospholipid homeostasis
Biological Processpositive regulation of bile acid secretion
Biological Processprotein ubiquitination
Biological Processregulation of bile acid metabolic process
Biological Processregulation of fatty acid beta-oxidation
Biological Processresponse to estrogen
Biological Processresponse to ethanol
Biological Processresponse to organic cyclic compound
Biological Processresponse to oxidative stress
Biological Processtransmembrane transport
Biological Processxenobiotic export from cell
Biological Processxenobiotic metabolic process
Biological Processxenobiotic transmembrane transport

Keywords

Enzyme and pathway databases

Protein family/group databases

Chemistry

Names & Taxonomy

Protein names

  • Recommended name
    Bile salt export pump
  • EC number
  • Alternative names
    • ATP-binding cassette sub-family B member 11

Gene names

    • Name
      ABCB11
    • Synonyms
      BSEP

Organism names

  • Taxonomic identifier
  • Taxonomic lineage
    Eukaryota > Metazoa > Chordata > Craniata > Vertebrata > Euteleostomi > Mammalia > Eutheria > Euarchontoglires > Primates > Haplorrhini > Catarrhini > Hominidae > Homo

Accessions

  • Primary accession
    O95342
  • Secondary accessions
    • Q53TL2
    • Q9UNB2

Proteomes

Organism-specific databases

Subcellular Location

Apical cell membrane
; Multi-pass membrane protein
Recycling endosome membrane
; Multi-pass membrane protein
Endosome
Cell membrane
; Multi-pass membrane protein
Note: Internalized at the canalicular membrane through interaction with the adapter protein complex 2 (AP-2) (PubMed:22262466).
At steady state, localizes in the canalicular membrane but is also present in recycling endosomes. ABCB11 constantly and rapidly exchanges between the two sites through tubulo-vesicles carriers that move along microtubules. Microtubule-dependent trafficking of ABCB11 is enhanced by taurocholate and cAMP and regulated by STK11 through a PKA-mediated pathway. Trafficking of newly synthesized ABCB11 through endosomal compartment to the bile canalicular membrane is accelerated by cAMP but not by taurocholate (By similarity).
Cell membrane expression is up-regulated by short- and medium-chain fatty acids (PubMed:20398791).

Features

Showing features for topological domain, transmembrane.

TypeIDPosition(s)Description
Topological domain1-62Cytoplasmic
Transmembrane63-83Helical
Topological domain84-147Extracellular
Transmembrane148-168Helical
Topological domain169-215Cytoplasmic
Transmembrane216-236Helical
Topological domain237-240Extracellular
Transmembrane241-261Helical
Topological domain262-319Cytoplasmic
Transmembrane320-340Helical
Topological domain341-353Extracellular
Transmembrane354-374Helical
Topological domain375-755Cytoplasmic
Transmembrane756-776Helical
Topological domain777-794Extracellular
Transmembrane795-815Helical
Topological domain816-869Cytoplasmic
Transmembrane870-890Helical
Transmembrane891-911Helical
Topological domain912-979Cytoplasmic
Transmembrane980-1000Helical
Topological domain1001-1011Extracellular
Transmembrane1012-1032Helical
Topological domain1033-1321Cytoplasmic

Keywords

Disease & Variants

Involvement in disease

Cholestasis, progressive familial intrahepatic, 2 (PFIC2)

  • Note
    • The disease is caused by variants affecting the gene represented in this entry
  • Description
    A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. PFIC2 inheritance is autosomal recessive.
  • See also
    MIM:601847
Natural variants in PFIC2
Variant IDPosition(s)ChangeDescription
VAR_083783129C>Yin PFIC2; loss of cell membrane localization; significantly reduces taurocholate transport activity; dbSNP:rs1695246652
VAR_030388238G>Vin PFIC2; dbSNP:rs72551306
VAR_013332284V>Lin PFIC2
VAR_010271297E>Gin PFIC2 and BRIC2; reduces transport capacity for taurocholate; decreases protein expression; affects maturation of protein in the reticulum endoplasmic; does not affect apical membrane localization; does not affect cell surface expression of the mature form; does not affect transport of taurocholate and glycocholate; enhances ubiquitination susceptibility; reduces transport activity of taurocholate in a low cholesterol environment; increases transport activity of taurocholate in a high cholesterol environment; does not affect protein expression; does not affect cell membrane localization; dbSNP:rs11568372
VAR_030390336C>Sin PFIC2; dbSNP:rs72551305
VAR_073967337Y>Hin PFIC2; uncertain significance
VAR_013334461K>Ein PFIC2; dbSNP:rs1274558905
VAR_073968472Y>Cin PFIC2; dbSNP:rs369860506
VAR_013335482D>Gin PFIC2; decreases protein expression; affects maturation of protein in the reticulum endoplasmic; decreases apical membrane localization; affects cell surface expression; does not affect transport of taurocholate and glycocholate; enhances ubiquitination susceptibility; dbSNP:rs72549402
VAR_073969696R>Win PFIC2; uncertain significance; dbSNP:rs376216286
VAR_073970931Q>Pin PFIC2; uncertain significance
VAR_013336982G>Rin PFIC2; impairs taurocholate transport activity; significantly reduces protein expression; decreases cell surface protein expression; loss of ell membrane localization; dbSNP:rs72549399
VAR_0133371004G>Din PFIC2
VAR_0739711131D>Vin PFIC2
VAR_0133381153R>Cin PFIC2; impairs taurocholate transport activity; significantly reduces protein expression; decreases cell surface protein expression; loss of ell membrane localization; dbSNP:rs72549395
VAR_0739721198H>Rin PFIC2; uncertain significance
VAR_0133391268R>Qin PFIC2; dbSNP:rs72549394

Cholestasis, benign recurrent intrahepatic, 2 (BRIC2)

  • Note
    • The disease is caused by variants affecting the gene represented in this entry
  • Description
    A disorder characterized by intermittent episodes of cholestasis without progression to liver failure. There is initial elevation of serum bile acids, followed by cholestatic jaundice which generally spontaneously resolves after periods of weeks to months. The cholestatic attacks vary in severity and duration. Patients are asymptomatic between episodes, both clinically and biochemically.
  • See also
    MIM:605479
Natural variants in BRIC2
Variant IDPosition(s)ChangeDescription
VAR_030386186E>Gin BRIC2; dbSNP:rs72551307
VAR_010271297E>Gin PFIC2 and BRIC2; reduces transport capacity for taurocholate; decreases protein expression; affects maturation of protein in the reticulum endoplasmic; does not affect apical membrane localization; does not affect cell surface expression of the mature form; does not affect transport of taurocholate and glycocholate; enhances ubiquitination susceptibility; reduces transport activity of taurocholate in a low cholesterol environment; increases transport activity of taurocholate in a high cholesterol environment; does not affect protein expression; does not affect cell membrane localization; dbSNP:rs11568372
VAR_030391432R>Tin BRIC2; reduced transport capacity for taurocholate; reduces transport activity of taurocholate in a low cholesterol environment; increases transport activity of taurocholate in a high cholesterol environment; dbSNP:rs121908935
VAR_030392570A>Tin BRIC2; dbSNP:rs886043807
VAR_030394923T>Pin BRIC2; dbSNP:rs777469571
VAR_030395926A>Pin BRIC2; dbSNP:rs72549400
VAR_0303961050R>Cin BRIC2; dbSNP:rs72549398
VAR_0303971128R>Hin BRIC2; dbSNP:rs756220860

Features

Showing features for mutagenesis, natural variant.

TypeIDPosition(s)Description
Mutagenesis1-441Does not affect ATPase-coupled bile acid transport activity. Decreases protein stability.
Natural variantVAR_05547256does not affect taurocholate transport activity; does not affect cell surface protein expression; dbSNP:rs11568361
Natural variantVAR_083783129in PFIC2; loss of cell membrane localization; significantly reduces taurocholate transport activity; dbSNP:rs1695246652
Natural variantVAR_030386186in BRIC2; dbSNP:rs72551307
Natural variantVAR_030387206impairs taurocholate transport activity; does not affect protein expression; does not affect cell surface protein expression; does not affect cell membrane localization; dbSNP:rs11568357
Natural variantVAR_030388238in PFIC2; dbSNP:rs72551306
Natural variantVAR_035349284in dbSNP:rs200739891
Natural variantVAR_013332284in PFIC2
Natural variantVAR_010271297in PFIC2 and BRIC2; reduces transport capacity for taurocholate; decreases protein expression; affects maturation of protein in the reticulum endoplasmic; does not affect apical membrane localization; does not affect cell surface expression of the mature form; does not affect transport of taurocholate and glycocholate; enhances ubiquitination susceptibility; reduces transport activity of taurocholate in a low cholesterol environment; increases transport activity of taurocholate in a high cholesterol environment; does not affect protein expression; does not affect cell membrane localization; dbSNP:rs11568372
Natural variantVAR_030389299in dbSNP:rs2287617
Natural variantVAR_030390336in PFIC2; dbSNP:rs72551305
Natural variantVAR_073967337in PFIC2; uncertain significance
Natural variantVAR_043074415in dbSNP:rs371656014
Natural variantVAR_030391432in BRIC2; reduced transport capacity for taurocholate; reduces transport activity of taurocholate in a low cholesterol environment; increases transport activity of taurocholate in a high cholesterol environment; dbSNP:rs121908935
Natural variantVAR_013333444does not affect transport capacity for taurocholate; increases transport activity of taurocholate in a low cholesterol environment; increases transport activity of taurocholate in a high cholesterol environment; does not affect cell surface protein expression; does not affect protein expression; dbSNP:rs2287622
Natural variantVAR_059106444in dbSNP:rs2287622
Natural variantVAR_059107444in dbSNP:rs2287622
Natural variantVAR_013334461in PFIC2; dbSNP:rs1274558905
Natural variantVAR_073968472in PFIC2; dbSNP:rs369860506
Natural variantVAR_013335482in PFIC2; decreases protein expression; affects maturation of protein in the reticulum endoplasmic; decreases apical membrane localization; affects cell surface expression; does not affect transport of taurocholate and glycocholate; enhances ubiquitination susceptibility; dbSNP:rs72549402
Natural variantVAR_083784558impairs taurocholate transport activity; does not affect protein expression; does not affect cell surface protein expression; does not affect cell membrane localization; dbSNP:rs11568369
Natural variantVAR_030392570in BRIC2; dbSNP:rs886043807
Natural variantVAR_043075591in a patient with intrahepatic cholestasis of pregnancy; impairs taurocholate transport activity; does not affect protein expression; does not affect cell surface protein expression; does not affect cell membrane localization; dbSNP:rs11568367
Natural variantVAR_083785592does not affect taurocholate transport activity; does not affect protein expression; does not affect cell surface protein expression; dbSNP:rs11568370
Natural variantVAR_035350616
Natural variantVAR_035351619in dbSNP:rs912519986
Natural variantVAR_043076676in fluvastatin-induced cholestasis; does not affect transport capacity for taurocholate
Natural variantVAR_030393677does not affect taurocholate transport activity; does not affect protein expression; does not affect cell surface protein expression; dbSNP:rs11568364
Natural variantVAR_073969696in PFIC2; uncertain significance; dbSNP:rs376216286
Natural variantVAR_035352698in dbSNP:rs138642043
Natural variantVAR_043077855in ethinylestradiol/gestodene-induced cholestasis; loss of transport capacity for taurocholate
Natural variantVAR_035353865deacreases localization to the cell membrane; decreases the trafficking to the plasma membrane; dbSNP:rs118109635
Natural variantVAR_030394923in BRIC2; dbSNP:rs777469571
Natural variantVAR_030395926in BRIC2; dbSNP:rs72549400
Natural variantVAR_073970931in PFIC2; uncertain significance
Natural variantVAR_035354958in dbSNP:rs761363245
Natural variantVAR_013336982in PFIC2; impairs taurocholate transport activity; significantly reduces protein expression; decreases cell surface protein expression; loss of ell membrane localization; dbSNP:rs72549399
Natural variantVAR_0133371004in PFIC2
Natural variantVAR_0303961050in BRIC2; dbSNP:rs72549398
Natural variantVAR_0303971128in BRIC2; dbSNP:rs756220860
Natural variantVAR_0739711131in PFIC2
Natural variantVAR_0133381153in PFIC2; impairs taurocholate transport activity; significantly reduces protein expression; decreases cell surface protein expression; loss of ell membrane localization; dbSNP:rs72549395
Natural variantVAR_0303981186impairs taurocholate transport activity; does not affect protein expression; decreases cell surface protein expression; reduces plasma membrane localization; dbSNP:rs1521808
Natural variantVAR_0739721198in PFIC2; uncertain significance
Natural variantVAR_0133391268in PFIC2; dbSNP:rs72549394
Mutagenesis1311Loss of interaction with AP2A1 and AP2A2. Promotes ABCB11 plasma membrane trafficking. Does not affect plasma membrane localization. Inhibits ABCB11 internalization.

Variants

We now provide the "Disease & Variants" viewer in its own tab.

The viewer provides 1,669 variants from UniProt as well as other sources including ClinVar and dbSNP.

Go to variant viewer

Keywords

Organism-specific databases

Miscellaneous

Chemistry

Genetic variation databases

PTM/Processing

Features

Showing features for chain, glycosylation, modified residue.

TypeIDPosition(s)Description
ChainPRO_00000932961-1321Bile salt export pump
Glycosylation109N-linked (GlcNAc...) asparagine
Glycosylation116N-linked (GlcNAc...) asparagine
Glycosylation122N-linked (GlcNAc...) asparagine
Glycosylation125N-linked (GlcNAc...) asparagine
Modified residue586Phosphothreonine
Modified residue587Phosphoserine
Modified residue690Phosphoserine
Modified residue701Phosphoserine
Modified residue704Phosphoserine
Modified residue1214Phosphoserine
Modified residue1321Phosphoserine

Post-translational modification

N-glycosylated.
Ubiquitinated; short-chain ubiquitination regulates cell-Surface expression of ABCB11.

Keywords

Proteomic databases

PTM databases

Expression

Tissue specificity

Expressed predominantly, if not exclusively in the liver, where it was further localized to the canalicular microvilli and to subcanalicular vesicles of the hepatocytes by in situ.

Gene expression databases

Organism-specific databases

Interaction

Subunit

Interacts with HAX1 (By similarity).
Interacts with the adapter protein complex 2 (AP-2) throught AP2A2 or AP2A1; this interaction regulates cell membrane expression of ABCB11 through its internalization in a clathrin-dependent manner and its subsequent degradation (PubMed:22262466).

Binary interactions

TypeEntry 1Entry 2Number of experimentsIntact
BINARY O95342DDIT4L Q96D033EBI-3914067, EBI-742054

Protein-protein interaction databases

Chemistry

Miscellaneous

Family & Domains

Features

Showing features for region, domain.

TypeIDPosition(s)Description
Region16-37Disordered
Domain62-385ABC transmembrane type-1 1
Domain420-656ABC transporter 1
Region651-672Interaction with HAX1
Domain755-1043ABC transmembrane type-1 2
Domain1078-1316ABC transporter 2
Region1311-1314Mediates internalization from the plasma membrane

Domain

Multifunctional polypeptide with two homologous halves, each containing a hydrophobic membrane-anchoring domain and an ATP binding cassette (ABC) domain.

Sequence similarities

Keywords

Phylogenomic databases

Family and domain databases

Sequence

  • Sequence status
    Complete
  • Length
    1,321
  • Mass (Da)
    146,407
  • Last updated
    2009-11-03 v2
  • Checksum
    61EE2173E2351D80
MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQLFRFSSSTDIWLMFVGSLCAFLHGIAQPGVLLIFGTMTDVFIDYDVELQELQIPGKACVNNTIVWTNSSLNQNMTNGTRCGLLNIESEMIKFASYYAGIAVAVLITGYIQICFWVIAAARQIQKMRKFYFRRIMRMEIGWFDCNSVGELNTRFSDDINKINDAIADQMALFIQRMTSTICGFLLGFFRGWKLTLVIISVSPLIGIGAATIGLSVSKFTDYELKAYAKAGVVADEVISSMRTVAAFGGEKREVERYEKNLVFAQRWGIRKGIVMGFFTGFVWCLIFLCYALAFWYGSTLVLDEGEYTPGTLVQIFLSVIVGALNLGNASPCLEAFATGRAAATSIFETIDRKPIIDCMSEDGYKLDRIKGEIEFHNVTFHYPSRPEVKILNDLNMVIKPGEMTALVGPSGAGKSTALQLIQRFYDPCEGMVTVDGHDIRSLNIQWLRDQIGIVEQEPVLFSTTIAENIRYGREDATMEDIVQAAKEANAYNFIMDLPQQFDTLVGEGGGQMSGGQKQRVAIARALIRNPKILLLDMATSALDNESEAMVQEVLSKIQHGHTIISVAHRLSTVRAADTIIGFEHGTAVERGTHEELLERKGVYFTLVTLQSQGNQALNEEDIKDATEDDMLARTFSRGSYQDSLRASIRQRSKSQLSYLVHEPPLAVVDHKSTYEEDRKDKDIPVQEEVEPAPVRRILKFSAPEWPYMLVGSVGAAVNGTVTPLYAFLFSQILGTFSIPDKEEQRSQINGVCLLFVAMGCVSLFTQFLQGYAFAKSGELLTKRLRKFGFRAMLGQDIAWFDDLRNSPGALTTRLATDASQVQGAAGSQIGMIVNSFTNVTVAMIIAFSFSWKLSLVILCFFPFLALSGATQTRMLTGFASRDKQALEMVGQITNEALSNIRTVAGIGKERRFIEALETELEKPFKTAIQKANIYGFCFAFAQCIMFIANSASYRYGGYLISNEGLHFSYVFRVISAVVLSATALGRAFSYTPSYAKAKISAARFFQLLDRQPPISVYNTAGEKWDNFQGKIDFVDCKFTYPSRPDSQVLNGLSVSISPGQTLAFVGSSGCGKSTSIQLLERFYDPDQGKVMIDGHDSKKVNVQFLRSNIGIVSQEPVLFACSIMDNIKYGDNTKEIPMERVIAAAKQAQLHDFVMSLPEKYETNVGSQGSQLSRGEKQRIAIARAIVRDPKILLLDEATSALDTESEKTVQVALDKAREGRTCIVIAHRLSTIQNADIIAVMAQGVVIEKGTHEELMAQKGAYYKLVTTGSPIS

Computationally mapped potential isoform sequences

There are 5 potential isoforms mapped to this entry

View all
EntryEntry nameGene nameLength
H7C486H7C486_HUMANABCB1172
Q53S60Q53S60_HUMANABCB11451
A0A3B3IS78A0A3B3IS78_HUMANABCB11780
A0A3B3ISD4A0A3B3ISD4_HUMANABCB11101
A0A3B3ITV9A0A3B3ITV9_HUMANABCB1181

Features

Showing features for sequence conflict.

TypeIDPosition(s)Description
Sequence conflict339in Ref. 1; AAC77455

Keywords

Sequence databases

Nucleotide SequenceProtein SequenceMolecule TypeStatus
AF091582
EMBL· GenBank· DDBJ
AAC77455.1
EMBL· GenBank· DDBJ
mRNA
AF136523
EMBL· GenBank· DDBJ
AAD28285.1
EMBL· GenBank· DDBJ
mRNA
AC008177
EMBL· GenBank· DDBJ
AAY24305.1
EMBL· GenBank· DDBJ
Genomic DNA
AC093723
EMBL· GenBank· DDBJ
-Genomic DNA No translation available.
AC069137
EMBL· GenBank· DDBJ
-Genomic DNA No translation available.

Genome annotation databases

Similar Proteins

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. Our staff consists of biologists and biochemists that are not trained to give medical advice.
We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.
FeedbackHelp